Search Within

Komal Lachhman Jhaveri

Refine Results
Formats
  1. Journal Article (30)
  2. Meeting Abstract (16)
Groups
  1. Breast Medicine Service (46)
  2. Solid Tumor Oncology Division (46)
  3. Breast Cancer Disease Management Team (33)
  4. Survivorship Research (22)
  5. Radiology, Department of (20)
  6. Epidemiology and Biostatistics (17)

More Groups

People
  1. Clifford Hudis (19)
  2. Shanu Modi (16)
  3. Sujata Patil (14)
  4. Gary Ulaner (11)
  5. Diana Lake (7)
  6. Maura Dickler (7)

More People

Years
  1. 2019 (2)
  2. 2018 (9)
  3. 2017 (8)
  4. 2016 (5)
  5. 2015 (3)
  6. 2014 (3)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer Research (5)
  3. Annals of Oncology (3)
  4. Clinical Cancer Research (3)
  5. Journal of Nuclear Medicine (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (9)
  3. Elsevier Inc. (4)
  4. Wiley Blackwell (4)
  5. Oxford University Press (3)
  6. Society of Nuclear Medicine (3)

More Publishers

Results (46)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Balancing the risks and benefits of extended adjuvant endocrine therapy
    Journal Article

    Jhaveri, K. L.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Targeting apoptosis: A new paradigm for the treatment of estrogen receptor-positive breast cancer
    Journal Article

    Drago, J. Z.; Chandarlapaty, S.; Jhaveri, K.
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Co-targeting ER and FGFR in patients with ER+/HER2- FGFR amplified (amp) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Syed, U.; Wong, S.; D'Andrea, G.; Lake, D.; Goldfarb, S.; Gajria, D.; Ligresti, L.; Rogado, A.; Reis-Filho, J.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial
    Meeting Abstract

    Jhaveri, K. L.; Makker, V.; Wang, X. V.; Chen, A. P.; Flaherty, K.; Conley, B. A.; O'Dwyer, P. J.; Williams, P. M.; Hamilton, S. R.; Harris, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 Oral SERD phase I trial
    Journal Article

    Paoletti, C.; Schiavon, G.; Dolce, E. M.; Darga, E. P.; Hedley Carr, T.; Geradts, J.; Hoch, M.; Klinowska, T.; Lindemann, J.; Marshall, G.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER(+)/HER2(-) advanced breast cancer
    Journal Article

    Hamilton, E. P.; Patel, M. R.; Armstrong, A. C.; Baird, R. D.; Jhaveri, K.; Hoch, M.; Klinowska, T.; Lindemann, J. P. O.; Morgan, S. R.; Schiavon, G.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • First-in-human human epidermal growth factor receptor 2-targeted imaging using (89)Zr-Pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer
    Journal Article

    Ulaner, G. A.; Lyashchenko, S. K.; Riedl, C.; Ruan, S.; Zanzonico, P. B.; Lake, D.; Jhaveri, K.; Zeglis, B.; Lewis, J. S.; O'Donoghue, J. A.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Phase I/Ib study of the SERD LSZ102 alone or in combination with ribociclib in ER+ breast cancer
    Meeting Abstract

    Juric, D.; Curigliano, G.; Cresta, S.; Yap, Y. S.; Terret, C.; Duhoux, F. P.; Takahashi, S.; Kundamal, N.; Bhansali, S.; Liao, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer
    Journal Article

    Kwa, M.; Li, X.; Novik, Y.; Oratz, R.; Jhaveri, K.; Wu, J.; Gu, P.; Meyers, M.; Muggia, F.; Speyer, J.; more...
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save